-
Je něco špatně v tomto záznamu ?
Red palm oil supplementation does not increase blood glucose or serum lipids levels in Wistar rats with different thyroid status
H. Rauchová, M. Vokurková, S. Pavelka, I. Vaněčková, N. Tribulová, T. Soukup
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
Grantová podpora
NV15-25396A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- glutathion metabolismus MeSH
- hormony štítné žlázy krev MeSH
- hypertyreóza metabolismus MeSH
- hypotyreóza metabolismus MeSH
- jaterní mitochondrie účinky léků metabolismus MeSH
- játra účinky léků metabolismus MeSH
- krevní glukóza metabolismus MeSH
- krysa rodu rattus MeSH
- ledviny účinky léků metabolismus MeSH
- lipidy krev MeSH
- palmový olej farmakologie MeSH
- potkani Wistar MeSH
- potravní doplňky * MeSH
- štítná žláza metabolismus MeSH
- tělesná hmotnost účinky léků MeSH
- velikost orgánu účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Red palm oil (RPO) is a rich natural source of antioxidant vitamins, namely carotenes, tocopherols and tocotrienols. However, it contains approximately 50 % saturated fatty acids the regular consumption of which could negatively modify lipid profile. The aim of our study was to test whether 7 weeks of RPO supplementation (1 g/kg body weight/day) would affect blood glucose and lipid metabolism in adult male Wistar rats with altered thyroid status. We induced hypothyroidism and hyperthyroidism in rats by oral administration of either methimazole or mixture of thyroid hormones. Different thyroid status (EU - euthyroid, HY - hypothyroid and HT - hyperthyroid) was characterized by different serum thyroid hormones levels (total and free thyroxine and triiodothyronine), changes in the activity of a marker enzyme of thyroid status - liver mitochondrial glycerol-3-phosphate dehydrogenase, and altered absolute and relative heart weights. Fasting blood glucose levels were higher in HT rats in comparison with EU and HY rats, but the changes caused by RPO supplementation were not significant. The achievement of the HY status significantly increased serum levels of total cholesterol, as well as with high-density lipoprotein-cholesterol and low-density lipoprotein-cholesterol: 2.43+/-0.15, 1.48+/-0.09, 0.89+/-0.08 mmol/l, compared to EU: 1.14+/-0.06, 0.77+/-0.06, 0.34+/-0.05 mmol/l and HT: 1.01+/-0.06, 0.69+/-0.04, 0.20+/-0.03 mmol/l, respectively. RPO supplementation did not increase significantly levels of blood lipids but tended to increase glutathione levels in the liver. In conclusion, RPO supplementation did not induce the presumed deterioration of glucose and lipid metabolism in rats with three well-characterized alterations in thyroid status.
Institute for Heart Research Slovak Academy of Sciences Bratislava Slovak Republic
Institute of Physiology of the Czech Academy of Sciences Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18036406
- 003
- CZ-PrNML
- 005
- 20181102123637.0
- 007
- ta
- 008
- 181030s2018 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933834 $2 doi
- 035 __
- $a (PubMed)29303614
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Rauchová, Hana, $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic $d 1950- $7 xx0074209
- 245 10
- $a Red palm oil supplementation does not increase blood glucose or serum lipids levels in Wistar rats with different thyroid status / $c H. Rauchová, M. Vokurková, S. Pavelka, I. Vaněčková, N. Tribulová, T. Soukup
- 520 9_
- $a Red palm oil (RPO) is a rich natural source of antioxidant vitamins, namely carotenes, tocopherols and tocotrienols. However, it contains approximately 50 % saturated fatty acids the regular consumption of which could negatively modify lipid profile. The aim of our study was to test whether 7 weeks of RPO supplementation (1 g/kg body weight/day) would affect blood glucose and lipid metabolism in adult male Wistar rats with altered thyroid status. We induced hypothyroidism and hyperthyroidism in rats by oral administration of either methimazole or mixture of thyroid hormones. Different thyroid status (EU - euthyroid, HY - hypothyroid and HT - hyperthyroid) was characterized by different serum thyroid hormones levels (total and free thyroxine and triiodothyronine), changes in the activity of a marker enzyme of thyroid status - liver mitochondrial glycerol-3-phosphate dehydrogenase, and altered absolute and relative heart weights. Fasting blood glucose levels were higher in HT rats in comparison with EU and HY rats, but the changes caused by RPO supplementation were not significant. The achievement of the HY status significantly increased serum levels of total cholesterol, as well as with high-density lipoprotein-cholesterol and low-density lipoprotein-cholesterol: 2.43+/-0.15, 1.48+/-0.09, 0.89+/-0.08 mmol/l, compared to EU: 1.14+/-0.06, 0.77+/-0.06, 0.34+/-0.05 mmol/l and HT: 1.01+/-0.06, 0.69+/-0.04, 0.20+/-0.03 mmol/l, respectively. RPO supplementation did not increase significantly levels of blood lipids but tended to increase glutathione levels in the liver. In conclusion, RPO supplementation did not induce the presumed deterioration of glucose and lipid metabolism in rats with three well-characterized alterations in thyroid status.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krevní glukóza $x metabolismus $7 D001786
- 650 _2
- $a tělesná hmotnost $x účinky léků $7 D001835
- 650 12
- $a potravní doplňky $7 D019587
- 650 _2
- $a glutathion $x metabolismus $7 D005978
- 650 _2
- $a hypertyreóza $x metabolismus $7 D006980
- 650 _2
- $a hypotyreóza $x metabolismus $7 D007037
- 650 _2
- $a ledviny $x účinky léků $x metabolismus $7 D007668
- 650 _2
- $a lipidy $x krev $7 D008055
- 650 _2
- $a játra $x účinky léků $x metabolismus $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a jaterní mitochondrie $x účinky léků $x metabolismus $7 D008930
- 650 _2
- $a velikost orgánu $x účinky léků $7 D009929
- 650 _2
- $a palmový olej $x farmakologie $7 D000073878
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a štítná žláza $x metabolismus $7 D013961
- 650 _2
- $a hormony štítné žlázy $x krev $7 D013963
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vokurková, Martina, $d 1973- $7 xx0037678 $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Pavelka, Stanislav, $d 1949- $7 xx0093081 $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Vaněčková, Ivana, $d 1964- $7 xx0030586 $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Tribulová, Narcisa, $d 1946- $7 xx0104473 $u Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic
- 700 1_
- $a Soukup, Tomáš $7 xx0140789 $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 67, č. 2 (2018), s. 307-315
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29303614 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20181030 $b ABA008
- 991 __
- $a 20181102103444 $b ABA008
- 999 __
- $a ok $b bmc $g 1347829 $s 1033430
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 67 $c 2 $d 307-315 $e 20180105 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- GRA __
- $a NV15-25396A $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20181030